Clinical and molecular findings in multiple sclerosis patients with type 1 diabetes mellitus

Journal of Clinical Neuroscience

Volumn 6, Issue 5, 1999, Pages 373-374

  Wandinger, Klaus Peter ^a,b   Trillenberg, Peter ^a   Klüter, Harald ^a   Wessel, Karl ^a   Kirchner, Holger ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Diabetes mellitus; Genetic susceptibility; HLA DQ; HLA DR; Multiple sclerosis

Indexed keywords

EID: 0009676995     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0967-5868(99)90027-9     Document Type: Article

References (10)

1. Warren S, Warren KG. Multiple sclerosis and associated diseases: a relationship to diabetes mellitus. Can J Neurol Sci 1981; 8: 35-39.
2. Wertman E, Zilber N, Abramsky O. An association between multiple sclerosis and type 1 diabetes mellitus. J Neurol 1992; 239: 43-45.
3. Thorsby E. Invited anniversary review: HLA associated diseases. Hum Immunol 1997; 53: 1-11.
4. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996; 46: 907-911.
5. Hillert J. Human leukocyte antigen studies in multiple sclerosis. Ann Neurol 1994; 36(Suppl): 15-17.
6. Zipp F, Weber F, Huber S et al. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-α by HLA-DR2+ T cells. Ann Neurol 1995; 38: 723-730.
7. Petrovsky N, Harrison LC. HLA class II-associated polymorphism of interferon-y production. Implications for HLA-disease association. Hum Immunol 1997; 53: 12-16.
8. Olerup O, Hillert J, Fredrikson S et al. Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci USA 1989; 86: 7113-7117.
9. De la Concha EG, Arroyo R, Crusius JBA et al. Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis. J Neuroimmunol 1997; 80: 172-178.
10. Berger T, Weerth S, Kojima K, Linington C, Wekerle H, Lassmann H. Experimental autoimmune encephalomyelitis - the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab Invest 1997; 76: 355-364.